Generic GMO soy opens lower cost market and could be boon for academic researchers

px Soybeanvarieties
Soybeanvarieties by Scott Bauer Licensed under Public Domain via Wikimedia Commons -

Monsanto’sย Roundup Ready seeds increased farmer’s yields, but came with a caveat. Because their pesticide resistance genes were patented, farmers had to shell out cash to Monsanto every year, instead of reusing seeds.ย Now, Monsantoโ€™s reign is (seemingly) beginning to end. Earlier this year, the patent on Monsantoโ€™s Roundup Ready soybean expired. Now, farmers can sowย generic genetically modified soybeans, and they can save the next generation of these seeds to replant next seasonโ€”all without paying Monsanto a penny.

When a big pharma company facesย a patent expiration, they reformulate. โ€œNewโ€ versions of a drug appearย around the time an original patent expires, with some slight tweak that suggests itโ€™ll work better.ย But slick marketing isnโ€™t likely to sway a farmer’sย purchasing decisionโ€”ย they’reย going to pay closer attention to hard numbers.

For now, the numbers are in Monsantoโ€™s favor. They released soybeans with the Genuity Roundup Ready 2 Yield trait several years ago.ย This modification actually works better than the original.

But the unlocking of Monsantoโ€™s patent might help the academic world.ย Now, universities canย continue research on the original Roundup Ready without paying licensing fees. Since they donโ€™t need to make money off of the seeds like a competing ag company would, academic labs can continue to experiment with slight tweaks on those seedsโ€” developing new versions that meet needs of a smaller subset of farmers.

Monsanto will continue to dominate the soybean seed market. But now that the technology is out in the open, more players can enter the field. These GM generics may not be a match for Monsanto now, but theyโ€™re edging closer to the ring.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post:ย Generic GMOs Arenโ€™t Going to Bring Down Monsantoโ€™s Empire

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDAโ€™s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint โ€” Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Farmers can talk to plants
Farmers are a major source of misinformationโ€”about farming
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health โ€” or even kill you
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of howย  the White House embraced the fringe claim that scientists are being mysteriously murdered
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTCโ€”a great idea. Hereโ€™s why itโ€™s unlikely to happen
Screenshot 2026-05-06 at 2.19
Vaccine shootout at the CDCย 
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.